ADIPOQ and type 2 diabetes mellitus: Lower serum adiponectin levels are correlated with insulin resistance pathophysiology and the development of type 2 diabetes mellitus (DM) due to an overexpression of inflammatory cytokines [3,4], and cardiovascular disease after vascular damage from the loss of proliferative smooth muscle cells and anti-atherogenic properties [5].